熱門資訊> 正文
CEL-SCI宣布定价570万美元
2025-07-12 03:04
- CEL-SCI (NYSE:CVM) announced on Friday the pricing of a best-efforts offering of 1,500,000 shares of its common stock.
- Each share of common stock is being sold at an offering price of $3.82 per share, priced at-the-market under NYSE American rules.
- Total gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, are expected to be approximately $5.7 million.
- The offering is expected to close on July 14, 2025.
- The company intends to use the net proceeds from the offering to fund the continued development of Multikine, general corporate purposes, and working capital.
- CVM is -1.17% to $3.775.
- Source: Press Release
More on Cel-Sci
- Editas Medicine, Cassava Sciences among healthcare stocks to join Russell Microcap; MNKD, OCGN to exit
- Biggest stock movers Thursday: Solar stocks, FNMA, and more
- Seeking Alpha’s Quant Rating on Cel-Sci
- Historical earnings data for Cel-Sci
- Financial information for Cel-Sci
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。